Significant Ownership of Thomas Meyer

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Thomas Meyer focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Thomas Meyer - Thomas Meyer
Manager location
Hamilton Hm 11, Bermuda

Significant Ownership of Thomas Meyer

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CYTOF Altamira Therapeutics Ltd. Common Stock, par value $0.002 per share 19% $107,984 1,079,843 Thomas Meyer 30 Apr 2025

Schedules 13D/G Reported by Thomas Meyer:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .